Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated
with the distributor of this clinical reference tool.
Abbreviations
ANC, absolute neutrophil count; bid, twice daily; CA-MRSA, community-acquired
MRSA; C & S, culture and sensitivity; CT, computed tomography; G-CSF, granulocyte
colony-stimulating factor; GI, gastrointestinal; GM-CSF, granulocyte-macrophage
colony-stimulating factor; h, hour; HSV, herpes simplex virus; I & D, incision and
drainage; IM, intramuscular; IV, intravenous; MASCC, Multinational Association
for Supportive Care; MRI, magnetic resonance imaging ; MRSA, methicillin-resistant
Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; N/A, not
applicable; PCR, polymerase chain reaction; PO, by mouth; qid, four times daily; S.
aureus, Staphylococcus aureus; Rx, prescription; SIRS, systemic inflammatory response
syndrome; SMX-TMP, sulfamethoxazole-trimethoprim; SSTI, skin and so-tissue
infection; tid, three times daily; u, units; VRE, vancomycin-resistant enterococci; VZV,
varicella zoster virus; WBC, white blood cell
Source
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A,
Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA Clinical Practice Guideline for
Vaccination of the Immunocompromised Host. Clin Infect Dis. 2014;58(3):e44-100.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies: info@GuidelineCentral.com
Copyright © 2014 All rights reserved
IDSASSTI14123c
